KCNJ5 and atrial fibrillation: This downregulation, marked specifically by decreased Kir3.1 and Kir3.4 subunit expressions in AF patients, serves as a potentially protective mechanism against the electrical remodeling-induced shortening of the atrial effective refractory period.